Filter By:

Journal Check one or more journals to show results from those journals only.

Choose more journals

Article type Check one or more article types to show results from those article types only.
Subject Check one or more subjects to show results from those subjects only.
Date Choose a date option to show results from those dates only.

Custom date range

Clear all filters
Sort by:
Showing 1–8 of 8 results
Advanced filters: Author: Jaap A Joles Clear advanced filters
  • Previous studies have indicated that ablation of renal sympathetic nerves reduces blood pressure in patients with resistant hypertension and preserved renal function. Hering et al. have now investigated the efficacy and safety of this procedure in patients with moderate to severe chronic kidney disease.

    • Peter J. Blankestijn
    • Jaap A. Joles
    News & Views
    Nature Reviews Nephrology
    Volume: 8, P: 439-440
  • Cardiorenal syndrome comprises a heterogeneous group of acute and chronic conditions, which affect patients with combined cardiac and renal dysfunction. Although cardiorenal syndrome is widely recognized, research in this field is hampered by the lack of a universally accepted definition and limited understanding of the hierarchy of factors involved in pathogenesis of the disease. Here, the authors discuss the current understanding of cardiorenal syndrome and suggest a roadmap for future research.

    • Branko Braam
    • Jaap A. Joles
    • Carlo A. Gaillard
    Reviews
    Nature Reviews Nephrology
    Volume: 10, P: 48-55
  • This wide-ranging introduction to new technologies for the management of renal failure touches on the optimization of conventional dialysis and on alternative techniques such as transplantation methods, artificial kidneys, tissue engineering strategies and harnessing the regenerative capacity of stem cells. The potential for other organs to 'host' renal functions, and the co-opting of developmental plasticity, are also discussed.

    • Branko Braam
    • Marianne C Verhaar
    • Jaap A Joles
    Reviews
    Nature Clinical Practice Nephrology
    Volume: 3, P: 564-572
  • The incretin hormone glucagon-like peptide 1 (GLP-1) has been implicated in the gut–renal axis and incretin-based therapies might reduce the burden of diabetic kidney disease. Here, the authors review the physiological roles of GLP-1, the potential renoprotective mechanisms of incretin-based therapies and the available renal outcome data from clinical trials.

    • Marcel H. A. Muskiet
    • Lennart Tonneijck
    • Daniël H. van Raalte
    Reviews
    Nature Reviews Nephrology
    Volume: 13, P: 605-628
  • Nephrotic syndrome is marked by excess of both protein in the urine (proteinuria) and triglycerides in the blood (hypertriglyceridemia). Sumant Chugh and his colleagues now explain these linked pathologies while also suggesting a possible new therapy to treat the proteinuria without aggravating the hypertriglyceridemia.

    • Lionel C Clement
    • Camille Macé
    • Sumant S Chugh
    Research
    Nature Medicine
    Volume: 20, P: 37-46